Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA)

Diabetes Research and Clinical Practice

Volumn 93, Issue 1, 2011, Pages

  Brophy, S ^a   Davies, H ^a   Dunseath, G ^b   Stephens, J W ^a   Platts, J ^c   Lane, H ^d   Beaverstock, C ^e   Wakeman, L ^f   Russell, I ^a   Williams, M ^g   Williams, D R R ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b Diabetes Research Laboratory   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

^d ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^e Neath Port Talbot Hospital   (United Kingdom)

^f ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

^g PRINCE PHILIP HOSPITAL   (United Kingdom)

Author keywords

GADA; Insulin; LADA; Trial

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; METFORMIN; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RESPONSE; FEMALE; HUMAN; HYPOGLYCEMIA; IMMUNOASSAY; INSULIN TREATMENT; LATENT AUTOIMMUNE DIABETES; MALE; PATIENT IDENTIFICATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 79960558425     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.04.004     Document Type: Article

References (12)

1. Brophy S., Yderstraede K., Mauricio D., Hunter S., Hawa M., Pozzilli P., et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 2008, 31(March (3)):439-441.
2. Brophy S., Brunt H., Davies H., Mannan S., Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev 2007, 3:CD006165.
3. Brophy S., Davies H., Bain S., Stephens J.W., Cheung W.Y., Richards K., et al. Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adults. BMC Endocr Disord 2008, 8:8.
4. Davies H., Brophy S., Fielding A., Bingley P., Chandler M., Hilldrup I., et al. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabet Med 2008 Nov, 25(11):1354-1357.
5. Glutamic Acid Decarboxylase (GAD) Autoantibody ELISA kit from RSR-instructions for use 2007 [cited 2009 13/03/09]. Available from: http://www.rsrltd.com/.
6. Torn C., Mueller P.W., Schlosser M., Bonifacio E., Bingley P.J. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008, 51(May (5)):846-852.
7. Davies H., Brophy S., Bain S.C., Stephens J.W., Lewis J., Luzio S., et al. GADA testing: the current state of knowledge. Prim Care Diabetes 2009, 3(August (3)):189-191.
8. Fourlanos S., Perry C., Stein M.S., Stankovich J., Harrison L.C., Colman P.G. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 2006, 29(May (5)):970-975.
9. Chaillous L., Bouhanick B., Kerlan V., Mathieu E., Lecomte P., Ducluzeau P.H., et al. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control. Diabetes Metab 2010, 36(February (1)):64-70.
10. Thunander M., Thorgeirsson H., Torn C., Petersson C. Landin-Olsson M. Beta-cell function and metabolic control in latent autoimmune diabetes in adults (LADA) with early insulin vs conventional treatment: a three-year follow-up. Eur J Endocrinol 2011, 164(2):239-245.
11. Davis T.M., Wright A.D., Mehta Z.M., Cull C.A., Stratton I.M., Bottazzo G.F., et al. Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 2005, 48(April (4)):695-702.
12. Maruyama T., Tanaka S., Shimada A., Funae O., Kasuga A., Kanatsuka A., et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 2008, 93(June (6)):2115-2121.